PGDS
阻害剤の選択性比較
| カタログ番号 | 製品カタログ | 溶解度(25°C) | ||
|---|---|---|---|---|
| 水 | DMSO | アルコール | ||
| S9678 | AT-56 | <1 mg/mL | 80 mg/mL | ''''<1 mg/mL |
| S0192 | HPGDS inhibitor 1 | ' mg/mL | ||
| S0484 | GSK-2894631A | ' mg/mL | ||
亜型選択性的な製品
PGDS製品
| 製品コード | 製品説明 | 文献中Selleckの製品使用例 | お客様のフィードバック |
|---|---|---|---|
| S9678 |
AT-56AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM. |
||
| S0192 |
HPGDS inhibitor 1HPGDS inhibitor 1 is a novel and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 of 0.7 nM. |
||
| S0484 |
GSK-2894631AGSK2894631A is an inhibitor of hematopoietic PGD synthase (HPGDS). |
| 製品コード | 製品説明 | 文献中Selleckの製品使用例 | お客様のフィードバック |
|---|---|---|---|
| S9678 |
AT-56AT-56 is an orally active and selective inhibitor of lipocalin-type prostaglandin (PG) D synthase (L-PGDS) with Ki of 75 μM and IC50 of 95 μM. |
||
| S0192 |
HPGDS inhibitor 1HPGDS inhibitor 1 is a novel and selective inhibitor of Hematopoietic Prostaglandin D Synthase (HPGDS) with IC50 of 0.7 nM. |
||
| S0484 |
GSK-2894631AGSK2894631A is an inhibitor of hematopoietic PGD synthase (HPGDS). |
